ProFunds > ProFunds
ProFund VP Biotechnology
$44.16M
Avg Monthly Net Assets
$43.29M
Total Assets
$1.12M
Total Liabilities
$42.18M
Net Assets
ProFund VP Biotechnology is an Underlying fund in ProFunds
from ProFunds,
based in Maryland,
United States of America.
The fund has one share class
and monthly net assets of $44.16M.
On August 27th, 2024 it reported 144 holdings, the largest
being SAREPTA THERAPEUTICS, INC. (3.3%), UNITED THERAPEUTICS CORPORATION (2.9%) and ALNYLAM PHARMACEUTICALS, INC. (2.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| ProFund VP Biotechnology | C000011092 |
Holdings
From latest NPORT-P, filed August 27th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS INC | Long | Equity-common | US | $122K | 6K | 0.29 |
| 89BIO INC | Long | Equity-common | US | $70K | 9K | 0.17 |
| ABBVIE INC (ABBVIE INC.) | Long | Equity-common | US | $1M | 7K | 2.71 |
| ACADIA PHARMACEUTICALS INC (ACADIA PHARMACEUTICALS INC.) | Long | Equity-common | US | $301K | 19K | 0.71 |
| ADMA BIOLOGICS INC (ADMA BIOLOGICS, INC.) | Long | Equity-common | US | $190K | 17K | 0.45 |
| AGIOS PHARMACEUTICALS INC | Long | Equity-common | US | $201K | 5K | 0.48 |
| AKERO THERAPEUTICS INC | Long | Equity-common | US | $172K | 7K | 0.41 |
| ALECTOR INC | Long | Equity-common | US | $28K | 6K | 0.07 |
| ALKERMES PLC (ALKERMES PUBLIC LIMITED COMPANY) | Long | Equity-common | IE | $422K | 17K | 1.00 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $59K | 25K | 0.14 |
| ALNYLAM PHARMACEUTICALS INC (ALNYLAM PHARMACEUTICALS, INC.) | Long | Equity-common | US | $1M | 5K | 2.83 |
| ALTIMMUNE INC (ALTIMMUNE, INC.) | Long | Equity-common | US | $89K | 13K | 0.21 |
| AMGEN INC (AMGEN INC.) | Long | Equity-common | US | $1M | 4K | 2.79 |
| AMICUS THERAPEUTICS INC (AMICUS THERAPEUTICS, INC.) | Long | Equity-common | US | $275K | 28K | 0.65 |
| ANAPTYSBIO INC | Long | Equity-common | US | $76K | 3K | 0.18 |
| ANAVEX LIFE SCIENCES CORP | Long | Equity-common | US | $57K | 14K | 0.14 |
| APELLIS PHARMACEUTICALS INC (APELLIS PHARMACEUTICALS, INC.) | Long | Equity-common | US | $563K | 15K | 1.33 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $179K | 5K | 0.42 |
| ARCELLX INC | Long | Equity-common | US | $287K | 5K | 0.68 |
| ARCTURUS THERAPEUTICS HOLDINGS INC | Long | Equity-common | US | $115K | 5K | 0.27 |
| ARCUS BIOSCIENCES INC | Long | Equity-common | US | $88K | 6K | 0.21 |
| ARCUTIS BIOTHERAPEUTICS INC | Long | Equity-common | US | $146K | 16K | 0.35 |
| ARDELYX INC | Long | Equity-common | US | $289K | 39K | 0.68 |
| ARROWHEAD PHARMACEUTICALS INC (ARROWHEAD PHARMACEUTICALS, INC.) | Long | Equity-common | US | $231K | 9K | 0.55 |
| ARS PHARMACEUTICALS INC | Long | Equity-common | US | $44K | 5K | 0.10 |
| ASTRIA THERAPEUTICS INC | Long | Equity-common | US | $61K | 7K | 0.14 |
| AVID BIOSERVICES INC (AVID BIOSERVICES, INC.) | Long | Equity-common | US | $80K | 11K | 0.19 |
| AVIDITY BIOSCIENCES INC | Long | Equity-common | US | $271K | 7K | 0.64 |
| BEAM THERAPEUTICS INC | Long | Equity-common | US | $235K | 10K | 0.56 |
| BIOCRYST PHARMACEUTICALS INC (BIOCRYST PHARMACEUTICALS, INC.) | Long | Equity-common | US | $175K | 28K | 0.41 |
| BIOGEN INC (BIOGEN INC.) | Long | Equity-common | US | $1M | 5K | 2.67 |
| BIOHAVEN LTD | Long | Equity-common | VG | $412K | 12K | 0.98 |
| BIOMARIN PHARMACEUTICAL INC (BIOMARIN PHARMACEUTICAL INC.) | Long | Equity-common | US | $1M | 13K | 2.63 |
| BLUEPRINT MEDICINES CORP (BLUEPRINT MEDICINES CORPORATION) | Long | Equity-common | US | $621K | 6K | 1.47 |
| BRIDGEBIO PHARMA INC (BRIDGEBIO PHARMA, INC.) | Long | Equity-common | US | $417K | 16K | 0.99 |
| C4 THERAPEUTICS INC | Long | Equity-common | US | $52K | 11K | 0.12 |
| CABALETTA BIO INC | Long | Equity-common | US | $47K | 6K | 0.11 |
| CAREDX INC (CAREDX, INC.) | Long | Equity-common | US | $84K | 5K | 0.20 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $40K | 2K | 0.10 |
| CATALYST PHARMACEUTICALS INC (CATALYST PHARMACEUTICALS, INC.) | Long | Equity-common | US | $174K | 11K | 0.41 |
| CELLDEX THERAPEUTICS INC (CELLDEX THERAPEUTICS, INC.) | Long | Equity-common | US | $268K | 7K | 0.64 |
| CEREVEL THERAPEUTICS HOLDINGS INC (CEREVEL THERAPEUTICS HOLDINGS, INC.) | Long | Equity-common | US | $455K | 11K | 1.08 |
| CG ONCOLOGY INC | Long | Equity-common | US | $98K | 3K | 0.23 |
| COGENT BIOSCIENCES INC | Long | Equity-common | US | $94K | 11K | 0.22 |
| CORBUS PHARMACEUTICALS HOLDINGS INC | Long | Equity-common | US | $64K | 1K | 0.15 |
| CREDIT AGRICOLE CIB NY | Long | Repurchase agreement | US | $77K | – | 0.18 |
| CRINETICS PHARMACEUTICALS INC | Long | Equity-common | US | $305K | 7K | 0.72 |
| CRISPR THERAPEUTICS AG | Long | Equity-common | CH | $598K | 11K | 1.42 |
| CULLINAN THERAPEUTICS INC | Long | Equity-common | US | $111K | 6K | 0.26 |
| CYTOKINETICS INC (CYTOKINETICS, INCORPORATED) | Long | Equity-common | US | $862K | 16K | 2.04 |
| DAY ONE BIOPHARMACEUTICALS INC | Long | Equity-common | US | $125K | 9K | 0.30 |
| DENALI THERAPEUTICS INC | Long | Equity-common | US | $213K | 9K | 0.51 |
| DISC MEDICINE INC | Long | Equity-common | US | $66K | 1K | 0.16 |
| DYNAVAX TECHNOLOGIES CORP (DYNAVAX TECHNOLOGIES CORPORATION) | Long | Equity-common | US | $212K | 19K | 0.50 |
| DYNE THERAPEUTICS INC | Long | Equity-common | US | $311K | 9K | 0.74 |
| EDITAS MEDICINE INC (EDITAS MEDICINE, INC.) | Long | Equity-common | US | $61K | 13K | 0.14 |
| EXACT SCIENCES CORP (EXACT SCIENCES CORPORATION) | Long | Equity-common | US | $1M | 27K | 2.69 |
| EXELIXIS INC (EXELIXIS, INC.) | Long | Equity-common | US | $476K | 21K | 1.13 |
| FATE THERAPEUTICS INC (FATE THERAPEUTICS, INC.) | Long | Equity-common | US | $50K | 15K | 0.12 |
| GERON CORP (GERON CORPORATION) | Long | Equity-common | US | $249K | 59K | 0.59 |
| GILEAD SCIENCES INC (GILEAD SCIENCES, INC.) | Long | Equity-common | US | $1M | 17K | 2.81 |
| HALOZYME THERAPEUTICS INC (HALOZYME THERAPEUTICS, INC.) | Long | Equity-common | US | $416K | 8K | 0.99 |
| HERON THERAPEUTICS INC (HERON THERAPEUTICS, INC.) | Long | Equity-common | US | $55K | 16K | 0.13 |
| HSBC SECURITIES USA INC | Long | Repurchase agreement | US | $146K | – | 0.35 |
| HUMACYTE INC | Long | Equity-common | US | $30K | 6K | 0.07 |
| IDEAYA BIOSCIENCES INC | Long | Equity-common | US | $256K | 7K | 0.61 |
| IMMUNITYBIO INC | Long | Equity-common | US | $167K | 26K | 0.40 |
| IMMUNOME INC | Long | Equity-common | US | $85K | 7K | 0.20 |
| IMMUNOVANT INC | Long | Equity-common | US | $225K | 9K | 0.53 |
| INCYTE PHARMACEUTICALS INC (INCYTE CORPORATION) | Long | Equity-common | US | $1M | 17K | 2.47 |
| INSMED INC (INSMED INCORPORATED) | Long | Equity-common | US | $456K | 7K | 1.08 |
| INTELLIA THERAPEUTICS INC (INTELLIA THERAPEUTICS, INC.) | Long | Equity-common | US | $283K | 13K | 0.67 |
| Invesco Government & Agency Portfolio (AGPXX) | Short-term investment vehicle | US | $1M | 1M | 2.43 | |
| IONIS PHARMACEUTICALS INC (IONIS PHARMACEUTICALS, INC.) | Long | Equity-common | US | $488K | 10K | 1.16 |
| IOVANCE BIOTHERAPEUTICS INC | Long | Equity-common | US | $328K | 41K | 0.78 |
| IRONWOOD PHARMACEUTICALS INC (IRONWOOD PHARMACEUTICALS, INC.) | Long | Equity-common | US | $152K | 23K | 0.36 |
| ITEOS THERAPEUTICS INC | Long | Equity-common | US | $32K | 2K | 0.08 |
| JANUX THERAPEUTICS INC | Long | Equity-common | US | $196K | 5K | 0.47 |
| KEROS THERAPEUTICS INC | Long | Equity-common | US | $160K | 3K | 0.38 |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC (Kiniksa Pharmaceuticals Ltd) | Long | Equity-common | BM | $69K | 4K | 0.16 |
| KRYSTAL BIOTECH INC | Long | Equity-common | US | $466K | 3K | 1.10 |
| KURA ONCOLOGY INC | Long | Equity-common | US | $156K | 8K | 0.37 |
| KYMERA THERAPEUTICS INC | Long | Equity-common | US | $164K | 6K | 0.39 |
| MADRIGAL PHARMACEUTICALS INC (MADRIGAL PHARMACEUTICALS, INC.) | Long | Equity-common | US | $619K | 2K | 1.47 |
| MANNKIND CORP (MANNKIND CORPORATION) | Long | Equity-common | US | $111K | 21K | 0.26 |
| MIMEDX GROUP INC (MIMEDX GROUP, INC.) | Long | Equity-common | US | $58K | 8K | 0.14 |
| MIRUM PHARMACEUTICALS INC (MIRUM PHARMACEUTICALS, INC.) | Long | Equity-common | US | $143K | 4K | 0.34 |
| MODERNA INC (MODERNA, INC.) | Long | Equity-common | US | $953K | 8K | 2.26 |
| MORPHIC HOLDING INC | Long | Equity-common | US | $154K | 5K | 0.37 |
| MYRIAD GENETICS INC (MYRIAD GENETICS, INC.) | Long | Equity-common | US | $139K | 6K | 0.33 |
| NATERA INC (NATERA, INC.) | Long | Equity-common | US | $1M | 10K | 2.56 |
| NATWEST MARKETS PLC | Long | Repurchase agreement | US | $68K | – | 0.16 |
| NEUROCRINE BIOSCIENCES INC (NEUROCRINE BIOSCIENCES, INC.) | Long | Equity-common | US | $1M | 7K | 2.39 |
| NOVAVAX INC (NOVAVAX, INC.) | Long | Equity-common | US | $201K | 16K | 0.48 |
| NURIX THERAPEUTICS INC | Long | Equity-common | US | $174K | 8K | 0.41 |
| NUVALENT INC | Long | Equity-common | US | $298K | 4K | 0.71 |
| OCUGEN INC | Long | Equity-common | US | $75K | 48K | 0.18 |
| OLEMA PHARMACEUTICALS INC | Long | Equity-common | US | $67K | 6K | 0.16 |
| ORIC PHARMACEUTICALS INC | Long | Equity-common | US | $50K | 7K | 0.12 |
| PRAXIS PRECISION MEDICINES INC | Long | Equity-common | US | $104K | 3K | 0.25 |
| PROTAGONIST THERAPEUTICS INC | Long | Equity-common | US | $158K | 5K | 0.38 |
| PROTHENA CORP PLC (Prothena Corporation PLC) | Long | Equity-common | IE | $121K | 6K | 0.29 |
| PTC THERAPEUTICS INC (PTC THERAPEUTICS, INC.) | Long | Equity-common | US | $186K | 6K | 0.44 |
| RECURSION PHARMACEUTICALS INC | Long | Equity-common | US | $181K | 24K | 0.43 |
| REGENERON PHARMACEUTICALS (REGENERON PHARMACEUTICALS, INC.) | Long | Equity-common | US | $1M | 1K | 2.70 |
| REGENXBIO INC | Long | Equity-common | US | $73K | 6K | 0.17 |
| RELAY THERAPEUTICS INC | Long | Equity-common | US | $77K | 12K | 0.18 |
| REVOLUTION MEDICINES INC | Long | Equity-common | US | $437K | 11K | 1.04 |
| RHYTHM PHARMACEUTICALS INC | Long | Equity-common | US | $181K | 4K | 0.43 |
| ROCKET PHARMACEUTICALS INC (ROCKET PHARMACEUTICALS, INC.) | Long | Equity-common | US | $154K | 7K | 0.36 |
| ROIVANT SCIENCES LTD | Long | Equity-common | BM | $532K | 50K | 1.26 |
| ROYAL BANK OF CANADA | Long | Repurchase agreement | US | $45K | – | 0.11 |
| SAGE THERAPEUTICS INC (SAGE THERAPEUTICS, INC.) | Long | Equity-common | US | $81K | 7K | 0.19 |
| SANA BIOTECHNOLOGY INC | Long | Equity-common | US | $113K | 21K | 0.27 |
| SAREPTA THERAPEUTICS INC (SAREPTA THERAPEUTICS, INC.) | Long | Equity-common | US | $1M | 9K | 3.28 |
| SAVARA INC (SAVARA INC.) | Long | Equity-common | US | $33K | 8K | 0.08 |
| SCHOLAR ROCK HOLDING CORP | Long | Equity-common | US | $67K | 8K | 0.16 |
| SOCIETE GENERALE | Long | Repurchase agreement | US | $119K | – | 0.28 |
| SOLENO THERAPEUTICS INC | Long | Equity-common | US | $133K | 3K | 0.32 |
| SPRINGWORKS THERAPEUTICS INC | Long | Equity-common | US | $356K | 9K | 0.84 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $96K | 4K | 0.23 |
| STOKE THERAPEUTICS INC | Long | Equity-common | US | $65K | 5K | 0.16 |
| SUMMIT THERAPEUTICS INC | Long | Equity-common | US | $78K | 10K | 0.19 |
| SYNDAX PHARMACEUTICALS INC | Long | Equity-common | US | $222K | 11K | 0.53 |
| TANGO THERAPEUTICS INC | Long | Equity-common | US | $38K | 4K | 0.09 |
| TG THERAPEUTICS INC (TG THERAPEUTICS, INC.) | Long | Equity-common | US | $364K | 20K | 0.86 |
| TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX | Derivative-equity | US | $-11K | – | -0.03 | |
| TRAVERE THERAPEUTICS INC (TRAVERE THERAPEUTICS, INC.) | Long | Equity-common | US | $91K | 11K | 0.22 |
| TWIST BIOSCIENCE CORP | Long | Equity-common | US | $308K | 6K | 0.73 |
| ULTRAGENYX PHARMACEUTICAL INC | Long | Equity-common | US | $314K | 8K | 0.75 |
| UMB FINANCIAL CORP | Long | Repurchase agreement | US | $7K | – | 0.02 |
| UNITED THERAPEUTICS CORP (UNITED THERAPEUTICS CORPORATION) | Long | Equity-common | US | $1M | 4K | 2.95 |
| VAXCYTE INC | Long | Equity-common | US | $434K | 6K | 1.03 |
| VERA THERAPEUTICS INC | Long | Equity-common | US | $267K | 7K | 0.63 |
| VERACYTE INC | Long | Equity-common | US | $145K | 7K | 0.34 |
| VERICEL CORP (VERICEL CORPORATION) | Long | Equity-common | US | $184K | 4K | 0.44 |
| VERTEX PHARMACEUTICALS INC (VERTEX PHARMACEUTICALS INCORPORATED) | Long | Equity-common | US | $1M | 2K | 2.60 |
| VERVE THERAPEUTICS INC | Long | Equity-common | US | $44K | 9K | 0.10 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $1M | 20K | 2.56 |
| VIR BIOTECHNOLOGY INC | Long | Equity-common | US | $79K | 9K | 0.19 |
| VIRIDIAN THERAPEUTICS INC | Long | Equity-common | US | $114K | 9K | 0.27 |
| VOYAGER THERAPEUTICS INC | Long | Equity-common | US | $43K | 5K | 0.10 |
| XENCOR INC | Long | Equity-common | US | $110K | 6K | 0.26 |
| ZENTALIS PHARMACEUTICALS INC | Long | Equity-common | US | $42K | 10K | 0.10 |
Address
ProFunds
7272 Wisconsin Avenue
21st Floor
Bethesda
Maryland
20814
United States of America
Websites
Directors
William D. Fertig
Russell S. Reynolds, III
Michael C. Wachs
Michael L. Sapir
Transfer Agents
FIS Investor Services LLC
Pricing Services
Bloomberg L.P.
Refinitiv US Holdings, Inc.
ICE Data Services
Custodians
UMB Bank, N.A.
Shareholder Servicing Agents
ProFunds Distributors, Inc.
Admins
Citi Fund Services Ohio, Inc.
Brokers
N/A